Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11346449 | 0.86 | FAAH (0.56) | FAAHTSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL1012855 | 0.85 | LMNA (0.46) | FAAHTSHRLMNAHSD17B10ALDH1A1 | |
| SCHEMBL7264660 | 0.84 | FAAH (0.54) | FAAHTSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL6602946 | 0.82 | TSHR (0.44) | FAAHTSHRLMNAHSD17B10ALDH1A1 | |
| SCHEMBL11154007 | 0.81 | FAAH (0.65) | FAAHTSHRCNR1CNR2EPHX2 | |
| SCHEMBL9668515 | 0.81 | FAAH (0.51) | FAAHTSHRCNR1CNR2 | |
| SCHEMBL136589 | 0.80 | — | — | |
| SCHEMBL229792 | 0.80 | TSHR (0.50) | TSHRLMNAHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL9049144 | 0.79 | FAAH (0.50) | FAAHCNR1CNR2 | |
| SCHEMBL9045868 | 0.79 | FAAH (0.50) | FAAHTSHRHSD17B10ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109053479-B | Method for synthesizing quaternary amine inner salt | 兆科药业（合肥）有限公司 | 2021-09-07 | — | — | CN | claimed |
| CN-105061338-A | 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system | PINGYUAN WEIFENG YONGZHU TECHNOLOGY CO LTD | 2015-11-18 | — | — | CN | claimed |
| US-4146724-A | PROCESS FOR THE MANUFACTURE OF ISOPROPYL 4-METHYLIMIDAZOLE-5-CARBOXYLATE | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | claimed |
| CN-109053479-B | Method for synthesizing quaternary amine inner salt | 兆科药业（合肥）有限公司 | 2021-09-07 | — | — | CN | disclosed |
| US-9580444-B2 | Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2017-02-28 | — | — | US | disclosed |
| US-9580444-B2 | Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2017-02-28 | — | — | US | disclosed |
| US-9580444-B2 | Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2017-02-28 | — | — | US | disclosed |
| US-20160024110-A1 | POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| US-20160024110-A1 | POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| US-20160024110-A1 | POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| EP-2975040-A1 | POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF | Sagami Chemical Research Institute (JP) | 2016-01-20 | — | — | EP | disclosed |
| US-4414400-A | FROM 4-HALOACETOACETIC ESTER, CYCLIZING ETHER CLEAVAGE OF 4-TERT-BUTOXYACETOACETIC ESTER | LONZA LTD. (CH) | 1983-11-08 | — | — | US | disclosed |
| US-4374252-A | Benzyl 5-methyl-4-imidazolecarboxylate | SK&F LAB CO. (US) | 1983-02-15 | — | — | US | disclosed |
| US-4328349-A | Process for preparing 5-methyl-4-imidazolecarboxylic acid esters | SK&F LAB CO. (US) | 1982-05-04 | — | — | US | disclosed |
| EP-0049638-A1 | Process for prepararing 5-methyl-4-imidazolecarboxylic acid esters | SMITHKLINE BECKMAN CORPORATION (US) | 1982-04-14 | — | — | EP | disclosed |
| US-4146724-A | PROCESS FOR THE MANUFACTURE OF ISOPROPYL 4-METHYLIMIDAZOLE-5-CARBOXYLATE | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
| US-4146724-A | PROCESS FOR THE MANUFACTURE OF ISOPROPYL 4-METHYLIMIDAZOLE-5-CARBOXYLATE | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
| US-4056551-A | DIMERIZATION OF V-HALOACETOACETATE | NIPPON GOHSEI KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-11-01 | — | — | US | disclosed |
| US-4039570-A | DISPERSING AGENTS | LONZA LTD. (CH) | 1977-08-02 | — | — | US | disclosed |
| US-4018821-A | Process for the production of carnitine | LONZA LTD. (CH) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024110-A1 | POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF | DDT, PDHX, CYP4X1 | FAAH 2622/4885TSHR 1207/4885LMNA 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.